Antibodies specific for Claudin 6 (CLDN6)

Details for Australian Patent Application No. 2010318316 (hide)

Owner Johannes Gutenberg-Universitat Mainz Ganymed Pharmaceuticals AG

Inventors Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael

Agent Dibbens Intellectual Property

Pub. Number AU-A-2010318316

PCT Pub. Number WO2011/057788

Priority 10006956.6 06.07.10 EP; 61/260,202 11.11.09 US; 09014136.7 11.11.09 EP; 61/361,618 06.07.10 US

Filing date 11 November 2010

Wipo publication date 19 May 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

26 April 2012 PCT application entered the National Phase

  PCT publication WO2011/057788 Priority application(s): WO2011/057788

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010318323-Anti integrin antibodies linked to nanoparticles loaded with chemotherapeutic agents

2010318312-Compounds for PIM kinase inhibition and for treating malignancy